id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-0134-0201,FDA,FDA-2013-N-0134,Mammography Quality Standards Act and Regulation Amendments: Small Entity Compliance Guide: Guidance for Industry and Food and Drug Administration Staff,Other,Guidance,2024-08-28T04:00:00Z,2024,8,2024-08-28T04:00:00Z,,2024-11-12T22:43:27Z,,1,0,09000064866b04ec
FDA-2013-N-0134-0200,FDA,FDA-2013-N-0134,Mammography Quality Standards Act and Regulation Amendments: Small Entity Compliance Guide; Guidance for Industry and Food and DrugAdministration Staff; Availability,Notice,Notice of Availability,2024-08-26T04:00:00Z,2024,8,,,2024-08-28T15:22:56Z,2024-19059,0,0,090000648669bf65
FDA-2013-N-0134-0199,FDA,FDA-2013-N-0134,Withdrawal of Approval and Amending of Mammography Quality Standards Act Alternative Standards,Notice,Withdrawal,2024-08-26T04:00:00Z,2024,8,,,2024-08-26T12:53:37Z,2024-19058,0,0,0900006486697b00
FDA-2013-N-0134-0198,FDA,FDA-2013-N-0134,Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals,Notice,Notice of Publication,2023-05-04T04:00:00Z,2023,5,2023-05-04T04:00:00Z,,2023-05-04T13:42:52Z,2023-09401,0,0,09000064859ca72d
FDA-2013-N-0134-0194,FDA,FDA-2013-N-0134,Tab B - Final Rule - Comparison OMB original to final version,Supporting & Related Material,Background Material,2023-03-20T04:00:00Z,2023,3,,,2023-03-20T19:59:50Z,,0,0,09000064857ff6da
FDA-2013-N-0134-0196,FDA,FDA-2013-N-0134,Tab C - FRIA - OMB final version,Supporting & Related Material,Background Material,2023-03-20T04:00:00Z,2023,3,,,2023-03-20T19:59:58Z,,0,0,09000064857ffc10
FDA-2013-N-0134-0197,FDA,FDA-2013-N-0134,Tab C - Rule - OMB final version,Supporting & Related Material,Background Material,2023-03-20T04:00:00Z,2023,3,,,2023-03-20T20:00:02Z,,0,0,09000064857ffc11
FDA-2013-N-0134-0193,FDA,FDA-2013-N-0134,Tab A - FRIA - OMB original version,Supporting & Related Material,Background Material,2023-03-20T04:00:00Z,2023,3,,,2023-03-20T19:59:45Z,,0,0,09000064857ff6d9
FDA-2013-N-0134-0192,FDA,FDA-2013-N-0134,Tab A - Final Rule - OMB original version,Supporting & Related Material,Background Material,2023-03-20T04:00:00Z,2023,3,,,2023-03-20T19:59:40Z,,0,0,09000064857ff6d8
FDA-2013-N-0134-0191,FDA,FDA-2013-N-0134,Memorandum to FDA DMS on Mammography Quality Standards Act,Supporting & Related Material,Background Material,2023-03-20T04:00:00Z,2023,3,,,2023-03-20T19:59:35Z,,0,0,09000064857ff6d7
FDA-2013-N-0134-0195,FDA,FDA-2013-N-0134,Tab B - FRIA - Comparison OMB original to final version,Supporting & Related Material,Background Material,2023-03-20T04:00:00Z,2023,3,,,2023-03-20T19:59:54Z,,0,0,09000064857ffc0f
FDA-2013-N-0134-0190,FDA,FDA-2013-N-0134,Mammography Quality Standards Act,Rule,Final Rule,2023-03-10T05:00:00Z,2023,3,2023-03-10T05:00:00Z,,2023-03-20T17:55:37Z,2023-04550,0,0,090000648578c535
FDA-2013-N-0134-0189,FDA,FDA-2013-N-0134,Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals,Notice,Notice of Approval,2023-02-14T05:00:00Z,2023,2,2023-02-14T05:00:00Z,,2023-02-14T14:48:44Z,2023-03073,0,0,0900006485692ff7
FDA-2013-N-0134-0188,FDA,FDA-2013-N-0134,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Mammography Quality Standards Act Requirements,Notice,30 Day Proposed Information Collection,2022-10-24T04:00:00Z,2022,10,2022-10-24T04:00:00Z,2022-11-24T04:59:59Z,2022-10-24T13:03:38Z,2022-23028,0,0,090000648544c9f4
FDA-2013-N-0134-0187,FDA,FDA-2013-N-0134,Agency Information Collection Activities; Proposed Collection; Comment Request; Mammography Quality Standards Act Requirements,Notice,60 Day Proposed Information Collection,2022-08-10T04:00:00Z,2022,8,2022-08-10T04:00:00Z,2022-10-12T03:59:59Z,2022-08-10T14:28:25Z,2022-17151,0,0,090000648522c391
FDA-2013-N-0134-0186,FDA,FDA-2013-N-0134,MQSA Ref 34 Eastern Research Group Inc. - Baseline Quality Measures,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2022-07-19T15:48:51Z,,0,0,0900006484be9251
FDA-2013-N-0134-0166,FDA,FDA-2013-N-0134,MQSA Ref 17 - Kolb 2002 Radiol,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:48:40Z,,0,0,0900006484be8c3d
FDA-2013-N-0134-0180,FDA,FDA-2013-N-0134,MQSA Ref 27 - Ho 2014 AJR,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T16:04:44Z,,0,0,0900006484be8c4e
FDA-2013-N-0134-0184,FDA,FDA-2013-N-0134,MQSA Ref 31 - ACR BI-RADS pp 7-8,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T16:10:00Z,,0,0,0900006484be8c51
FDA-2013-N-0134-0158,FDA,FDA-2013-N-0134,MQSA Ref 9 - ACR breast density brochure,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:37:40Z,,0,0,0900006484be8c14
FDA-2013-N-0134-0161,FDA,FDA-2013-N-0134,MQSA Ref 12 - Boyd 2007 NEJM,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:43:15Z,,0,0,0900006484be8c17
FDA-2013-N-0134-0150,FDA,FDA-2013-N-0134,MQSA Ref 1 - CDC - Breast Cancer Statistics,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:25:39Z,,0,0,0900006484be869b
FDA-2013-N-0134-0165,FDA,FDA-2013-N-0134,MQSA Ref 16 - CDC - What Are the Risk Factors for Breast Cancer_,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:46:57Z,,0,0,0900006484be8c3c
FDA-2013-N-0134-0170,FDA,FDA-2013-N-0134,MQSA Ref 21 - Dense Breast Info website,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:54:41Z,,0,0,0900006484be8c41
FDA-2013-N-0134-0160,FDA,FDA-2013-N-0134,MQSA Ref 11 - McCormack 2006 CEBP,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:42:17Z,,0,0,0900006484be8c16
FDA-2013-N-0134-0155,FDA,FDA-2013-N-0134,MQSA Ref 6 - GAO report 2006,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:32:55Z,,0,0,0900006484be8c11
FDA-2013-N-0134-0152,FDA,FDA-2013-N-0134,MQSA Ref 3 - CDC - Cancer Statistics - Cancer Among Women,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:28:03Z,,0,0,0900006484be869d
FDA-2013-N-0134-0175,FDA,FDA-2013-N-0134,MQSA Ref 22 - Transcript of Sept 29 2006 - 2nd part,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:59:33Z,,0,0,0900006484be8c49
FDA-2013-N-0134-0168,FDA,FDA-2013-N-0134,MQSA Ref 19 - Berg 2008 JAMA,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:53:17Z,,0,0,0900006484be8c3f
FDA-2013-N-0134-0172,FDA,FDA-2013-N-0134,MQSA Ref 22 - Transcript of Sept 28 2006 - 2nd part,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:57:15Z,,0,0,0900006484be8c43
FDA-2013-N-0134-0176,FDA,FDA-2013-N-0134,MQSA Ref 23 - MQSA Alternative Standard 11_ Modifica,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T16:00:12Z,,0,0,0900006484be8c4a
FDA-2013-N-0134-0169,FDA,FDA-2013-N-0134,MQSA Ref 20 - NMQAAC summary 2011,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:53:56Z,,0,0,0900006484be8c40
FDA-2013-N-0134-0173,FDA,FDA-2013-N-0134,MQSA Ref 22 - Transcript of Sept 28 2006 - 3rd part,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:57:58Z,,0,0,0900006484be8c44
FDA-2013-N-0134-0156,FDA,FDA-2013-N-0134,MQSA Ref 7 complete - US Senate Hearing 02-13-1991,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:35:04Z,,0,0,0900006484be8c12
FDA-2013-N-0134-0157,FDA,FDA-2013-N-0134,MQSA Ref 8 - US House Subcommittee Hearing 10-24-1991,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:36:29Z,,0,0,0900006484be8c13
FDA-2013-N-0134-0185,FDA,FDA-2013-N-0134,MQSA Ref 33 - FDA MQSA National Statistics 2018,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T16:10:48Z,,0,0,0900006484be9250
FDA-2013-N-0134-0177,FDA,FDA-2013-N-0134,MQSA Ref 24 - MQSA Alternative Standard 12_ Assessme,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T16:00:51Z,,0,0,0900006484be8c4b
FDA-2013-N-0134-0178,FDA,FDA-2013-N-0134,MQSA Ref 25 - Sickels ACR BI-RADS pp 123-126,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T16:02:56Z,,0,0,0900006484be8c4c
FDA-2013-N-0134-0154,FDA,FDA-2013-N-0134,MQSA Ref 5 - Americal Cancer Society - Breast Cancer Early Detection Recommendations,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:30:55Z,,0,0,0900006484be8c10
FDA-2013-N-0134-0159,FDA,FDA-2013-N-0134,MQSA Ref 10 - American College of Radiology-Society of Breast Imaging,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:38:37Z,,0,0,0900006484be8c15
FDA-2013-N-0134-0163,FDA,FDA-2013-N-0134,MQSA Ref 14- Gastounioti Beyond Breast Density 2016,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:45:12Z,,0,0,0900006484be8c19
FDA-2013-N-0134-0167,FDA,FDA-2013-N-0134,MQSA Ref 18 - Leconte 2003 AJR,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:49:30Z,,0,0,0900006484be8c3e
FDA-2013-N-0134-0171,FDA,FDA-2013-N-0134,MQSA Ref 22 - Transcript of Sept 28 2006 - 1st part,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:56:26Z,,0,0,0900006484be8c42
FDA-2013-N-0134-0179,FDA,FDA-2013-N-0134,MQSA Ref 26 - Am Cancer Soc breast density brochure,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T16:03:54Z,,0,0,0900006484be8c4d
FDA-2013-N-0134-0183,FDA,FDA-2013-N-0134,MQSA Ref 32 - Mammography_PRIA.FDA-2013-N-0134,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T16:09:04Z,,0,0,0900006484be8c50
FDA-2013-N-0134-0181,FDA,FDA-2013-N-0134,MQSA Ref 30 - ACR BI-RADS Outcomes Monitoring,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T16:05:55Z,,0,0,0900006484be924f
FDA-2013-N-0134-0182,FDA,FDA-2013-N-0134,MQSA Ref 28  - Melnikow 2016 Ann Int Med,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T16:07:13Z,,0,0,0900006484be8c4f
FDA-2013-N-0134-0164,FDA,FDA-2013-N-0134,MQSA Ref 15 - Guterbock 2017,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:45:58Z,,0,0,0900006484be8c3b
FDA-2013-N-0134-0174,FDA,FDA-2013-N-0134,MQSA Ref 22 - Transcript of Sept 29 2006 - 1st part,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:58:41Z,,0,0,0900006484be8c48
FDA-2013-N-0134-0151,FDA,FDA-2013-N-0134,MQSA Ref 2 - Female Breast Cancer - Cancer Stat Facts,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:27:05Z,,0,0,0900006484be869c
FDA-2013-N-0134-0153,FDA,FDA-2013-N-0134,MQSA Ref 4 - Michaelson 2002 Cancer,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:29:28Z,,0,0,0900006484be869e
FDA-2013-N-0134-0162,FDA,FDA-2013-N-0134,MQSA Ref 13 - Vachon 2007 Br Cancer Res,Supporting & Related Material,Background Material,2021-07-13T04:00:00Z,2021,7,,,2021-07-13T15:44:07Z,,0,0,0900006484be8c18
FDA-2013-N-0134-0149,FDA,FDA-2013-N-0134,"Agency Information Collection Activities; Announcement of Office of
Management and Budget Approvals",Notice,Notice of Approval,2019-12-31T05:00:00Z,2019,12,2019-12-31T05:00:00Z,,2019-12-31T14:47:33Z,2019-28249,0,0,090000648425d409
FDA-2013-N-0134-0148,FDA,FDA-2013-N-0134,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Comment Request; Mammography
Quality Standards Act Requirements",Notice,30 Day Proposed Information Collection,2019-08-19T04:00:00Z,2019,8,2019-08-19T04:00:00Z,2019-09-19T03:59:59Z,2019-08-19T13:00:42Z,2019-17734,0,0,0900006483e6b741
FDA-2013-N-0134-0081,FDA,FDA-2013-N-0134,Mammography Quality Standards Act; Amendments to Part 900 Regulations; Preliminary Regulatory Impact Analysis Initial Regulatory Flexibility Analysis Unfunded Mandates Reform Act Analysis,Supporting & Related Material,Background Material,2019-06-06T04:00:00Z,2019,6,,,2019-06-06T14:22:22Z,,0,0,0900006483cf15c4
FDA-2013-N-0134-0061,FDA,FDA-2013-N-0134,Agency Information Collection Activities; Proposed Collection; Comment Request; Mammography Quality Standards Act Requirements,Notice,60 Day Proposed Information Collection,2019-05-01T04:00:00Z,2019,5,2019-05-01T04:00:00Z,2019-07-02T03:59:59Z,2019-05-02T01:03:15Z,2019-08784,0,0,0900006483c22355
FDA-2013-N-0134-0006,FDA,FDA-2013-N-0134,Mammography Quality Standards Act,Proposed Rule,Amendment,2019-03-28T04:00:00Z,2019,3,2019-03-28T04:00:00Z,2019-06-27T03:59:59Z,2019-07-03T01:05:03Z,2019-05803,0,0,0900006483b38569
FDA-2013-N-0134-0005,FDA,FDA-2013-N-0134,"Agency Information Collection Activities; Announcement of Office of
Management and Budget Approvals",Notice,Notice of Approval,2016-12-14T05:00:00Z,2016,12,2016-12-14T05:00:00Z,,2016-12-14T16:02:06Z,2016-30035,0,0,090000648240823b
FDA-2013-N-0134-0004,FDA,FDA-2013-N-0134,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Comment Request; Mammography
Quality Standards Act Requirements",Notice,30 Day Proposed Information Collection,2016-08-19T04:00:00Z,2016,8,2016-08-19T04:00:00Z,2016-09-20T03:59:59Z,2016-08-19T14:32:42Z,2016-19808,0,0,09000064821842ce
FDA-2013-N-0134-0003,FDA,FDA-2013-N-0134,Agency Information Collection Activities; Proposed Collection; Comment Request; Mammography Quality Standards Act Requirements,Notice,60 Day Proposed Information Collection,2016-06-08T04:00:00Z,2016,6,2016-06-08T04:00:00Z,2016-08-09T03:59:59Z,2016-06-08T14:19:30Z,2016-13522,0,0,090000648201e58d
FDA-2013-N-0134-0002,FDA,FDA-2013-N-0134,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Mammography Quality Standards Act Requirements,Notice,30 Day Proposed Information Collection,2013-07-02T04:00:00Z,2013,7,2013-07-02T04:00:00Z,2013-08-02T03:59:59Z,2016-06-01T14:12:26Z,2013-15790,0,0,0900006481351691
FDA-2013-N-0134-0001,FDA,FDA-2013-N-0134,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Mammography Quality Standards Act Requirements",Notice,60 Day Proposed Information Collection,2013-02-28T05:00:00Z,2013,2,2013-02-28T05:00:00Z,2013-04-30T03:59:59Z,2016-06-01T14:11:15Z,2013-04677,0,0,090000648120f733